Updating results…
What is Kidney Transplant Phase 3 Belatacept BENEFIT?
NCT00256750 is belatacept evaluation of nephroprotection and efficacy as first-line immunosuppression trial. Other study IDs include: IM103-008, BENEFIT.
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| Transplant rejection prevention | 2 | 1 |
|
||||
See all 2 patients currently using Kidney Transplant Phase 3 Belatacept BENEFIT
Mouse over the table for more information
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Kidney Transplant Phase 3 Belatacept BENEFIT
Always |
1 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Kidney Transplant Phase 3 Belatacept BENEFIT
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
0 | 0% |
|
Not at all |
1 | 100% |
|
Cost
Paid out of pocket
Cost of Kidney Transplant Phase 3 Belatacept BENEFIT
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
1 | 100% |
|